Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case.


Journal

Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741

Informations de publication

Date de publication:
15 10 2022
Historique:
received: 12 09 2022
accepted: 29 09 2022
entrez: 15 10 2022
pubmed: 16 10 2022
medline: 19 10 2022
Statut: epublish

Résumé

People living with HIV/AIDS (PLWHA) show a reduced incidence for three cancer types, namely breast, prostate and colon cancers. In the present study, we assessed whether a molecular mimicry between HIV epitopes and tumor associated antigens and, consequently, a T cell cross-reactivity could provide an explanation for such an epidemiological evidence. Homology between published TAAs and non-self HIV-derived epitopes have been assessed by BLAST homology. Structural analyses have been performed by bioinformatics tools. Immunological validation of CD8 Sequence homologies between multiple TAAs and HIV epitopes have been found. High structural similarities between the paired TAAs and HIV epitopes as well as comparable patterns of contact with HLA and TCR α and β chains have been observed. Furthermore, cross-reacting CD8 This is the first study showing a molecular mimicry between HIV antigens an TAAs identified in breast, prostate and colon cancers. Therefore, it is highly reasonable that memory CD8

Sections du résumé

BACKGROUND
People living with HIV/AIDS (PLWHA) show a reduced incidence for three cancer types, namely breast, prostate and colon cancers. In the present study, we assessed whether a molecular mimicry between HIV epitopes and tumor associated antigens and, consequently, a T cell cross-reactivity could provide an explanation for such an epidemiological evidence.
METHODS
Homology between published TAAs and non-self HIV-derived epitopes have been assessed by BLAST homology. Structural analyses have been performed by bioinformatics tools. Immunological validation of CD8
FINDINGS
Sequence homologies between multiple TAAs and HIV epitopes have been found. High structural similarities between the paired TAAs and HIV epitopes as well as comparable patterns of contact with HLA and TCR α and β chains have been observed. Furthermore, cross-reacting CD8
INTERPRETATION
This is the first study showing a molecular mimicry between HIV antigens an TAAs identified in breast, prostate and colon cancers. Therefore, it is highly reasonable that memory CD8

Identifiants

pubmed: 36243758
doi: 10.1186/s12967-022-03681-4
pii: 10.1186/s12967-022-03681-4
pmc: PMC9569184
doi:

Substances chimiques

Epitopes, T-Lymphocyte 0
HIV Antigens 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

472

Informations de copyright

© 2022. The Author(s).

Références

Cell Host Microbe. 2021 Jul 14;29(7):1093-1110
pubmed: 34242582
Lancet. 2007 Jul 7;370(9581):59-67
pubmed: 17617273
Nucleic Acids Res. 2020 Jul 2;48(W1):W449-W454
pubmed: 32406916
Lancet Oncol. 2021 Jun;22(6):e240-e253
pubmed: 34087151
Mol Ther. 2021 Jan 6;29(1):10-12
pubmed: 33308440
J Transl Med. 2018 Oct 19;16(1):286
pubmed: 30340600
Semin Oncol. 2015 Apr;42(2):247-57
pubmed: 25843729
J Immunother Cancer. 2021 May;9(5):
pubmed: 34049932
PLoS Comput Biol. 2017 Aug 23;13(8):e1005725
pubmed: 28832583
Clin Cancer Res. 2004 Apr 15;10(8):2645-51
pubmed: 15102666
Nat Rev Immunol. 2012 Sep;12(9):669-77
pubmed: 22918468
J Acquir Immune Defic Syndr. 2009 Dec;52(5):611-22
pubmed: 19770804
N Engl J Med. 2014 Dec 4;371(23):2189-2199
pubmed: 25409260
J Biol Chem. 2012 Jan 6;287(2):1168-77
pubmed: 22102287
Ther Adv Med Oncol. 2021 Apr 29;13:17588359211011455
pubmed: 33995596
Lancet Infect Dis. 2010 May;10(5):305-16
pubmed: 20417413
Clin Cancer Res. 2004 Apr 15;10(8):2860-7
pubmed: 15102695
Nature. 2017 Nov 23;551(7681):512-516
pubmed: 29132146
Sci Immunol. 2019 Jul 19;4(37):
pubmed: 31324690
J Natl Cancer Inst. 2018 Sep 1;110(9):959-966
pubmed: 29529223
J Natl Cancer Inst. 2007 Jun 20;99(12):962-72
pubmed: 17565153
J Immunother Cancer. 2022 Mar;10(3):
pubmed: 35241495
J Gen Virol. 2003 Sep;84(Pt 9):2409-2421
pubmed: 12917462
Cancers (Basel). 2021 Dec 28;14(1):
pubmed: 35008303
Blood. 2009 Jul 9;114(2):346-56
pubmed: 19365081
Acta Neuropathol. 2018 Jun;135(6):923-938
pubmed: 29557506
PLoS One. 2018 Jan 3;13(1):e0190638
pubmed: 29298343
Nat Commun. 2016 May 23;7:11660
pubmed: 27212475

Auteurs

Carmen Manolio (C)

Innovative Immunological Models Unit, Istituto Nazionale Tumori - IRCCS - "Fond G. Pascale", Via Mariano Semmola, 52, Naples, Italy.

Concetta Ragone (C)

Innovative Immunological Models Unit, Istituto Nazionale Tumori - IRCCS - "Fond G. Pascale", Via Mariano Semmola, 52, Naples, Italy.

Beatrice Cavalluzzo (B)

Innovative Immunological Models Unit, Istituto Nazionale Tumori - IRCCS - "Fond G. Pascale", Via Mariano Semmola, 52, Naples, Italy.

Angela Mauriello (A)

Innovative Immunological Models Unit, Istituto Nazionale Tumori - IRCCS - "Fond G. Pascale", Via Mariano Semmola, 52, Naples, Italy.

Maria Lina Tornesello (ML)

Molecular Biology and Viral Oncogenesis Unit, Istituto Nazionale Tumori - IRCCS - "Fond G. Pascale", Naples, Italy.

Franco M Buonaguro (FM)

Molecular Biology and Viral Oncogenesis Unit, Istituto Nazionale Tumori - IRCCS - "Fond G. Pascale", Naples, Italy.

Angelo Salomone Megna (A)

Division of Infectious Diseases, AORN San Pio Hospital, Benevento, Italy.

Giovanna D'Alessio (G)

Division of Infectious Diseases, AORN San Pio Hospital, Benevento, Italy.

Roberta Penta (R)

Cellular Manipulation and Immunogenetics, Oncology Dep, Ba.S.C.O. Unit, AORN Santobono-Pausilipon, Naples, Italy.

Maria Tagliamonte (M)

Innovative Immunological Models Unit, Istituto Nazionale Tumori - IRCCS - "Fond G. Pascale", Via Mariano Semmola, 52, Naples, Italy.

Luigi Buonaguro (L)

Innovative Immunological Models Unit, Istituto Nazionale Tumori - IRCCS - "Fond G. Pascale", Via Mariano Semmola, 52, Naples, Italy. l.buonaguro@istitutotumori.na.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH